Stem Cell-Mediated Transfer of a Human Artificial Chromosome Ameliorates Muscular Dystrophy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stem Cell-Mediated Transfer of a Human Artificial Chromosome Ameliorates Muscular Dystrophy
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 3, Issue 96, Pages 96ra78-96ra78
Publisher
American Association for the Advancement of Science (AAAS)
Online
2011-08-18
DOI
10.1126/scitranslmed.3002342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells
- (2011) Mohammad A. Mandegar et al. HUMAN MOLECULAR GENETICS
- Therapeutic approaches to muscular dystrophy
- (2011) A. Goyenvalle et al. HUMAN MOLECULAR GENETICS
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway
- (2010) Davide Cacchiarelli et al. Cell Metabolism
- Human Artificial Chromosome with a Conditional Centromere for Gene Delivery and Gene Expression
- (2010) Y. Iida et al. DNA RESEARCH
- Refined human artificial chromosome vectors for gene therapy and animal transgenesis
- (2010) Y Kazuki et al. GENE THERAPY
- Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
- (2010) Richard S. Finkel JOURNAL OF CHILD NEUROLOGY
- Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells
- (2010) Francesco Saverio Tedesco et al. JOURNAL OF CLINICAL INVESTIGATION
- The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular Dystrophy
- (2010) Qi-Long Lu et al. MOLECULAR THERAPY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapy for neuromuscular disorders
- (2009) Andrea LH Arnett et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- Skeletal muscle stem cells in developmental versus regenerative myogenesis
- (2009) S. Tajbakhsh JOURNAL OF INTERNAL MEDICINE
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Dystrophin Delivery to Muscles of mdx Mice Using Lentiviral Vectors Leads to Myogenic Progenitor Targeting and Stable Gene Expression
- (2009) En Kimura et al. MOLECULAR THERAPY
- Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
- (2009) Yasuhiro Kazuki et al. MOLECULAR THERAPY
- Use of evans blue dye to compare limb muscles in exercised young and oldmdxmice
- (2009) Christine I. Wooddell et al. MUSCLE & NERVE
- Serum levels of vascular endothelial growth factor elevated in patients with muscular dystrophy
- (2008) Toshio Saito et al. BRAIN & DEVELOPMENT
- Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx Mice
- (2008) Paul Gregorevic et al. MOLECULAR THERAPY
- A highly Stable and Nonintegrated Human Artificial Chromosome (HAC) Containing the 2.4 Mb Entire Human Dystrophin Gene
- (2008) Hidetoshi Hoshiya et al. MOLECULAR THERAPY
- PlGF–MMP-9–expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle
- (2008) Cesare Gargioli et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started